Stanford researchers have developed SCOA-DUPI (Simulation-based Control Optimization Algorithm with Dynamic Uncertain Parameter Inversion), which relies on real-time data collected though embedded sensors that can be used to ease the operational challenges of Managed Aquifer R
Stanford researchers have developed a novel PET agent for diseases stemming from T cell origin. The probes help visualize the disease status as well as the progress of therapy.
Coronary artery bypass grafting (CABG) surgery is performed on nearly half a million patients with multivessel or diffuse coronary artery disease each year in the United States.
Inventors at Stanford have developed a novel strategy to perform concurrent fluorescence measurements of multiple biological parameters in freely moving and head-restrained animals.
The invention consists of the ability to treat inflammatory and autoimmune disorders, particularly but not exclusively those involving mucosal sites such as in the chronic inflammatory bowel disease, by blocking or altering 4B7 interactions with vascular and extracellular matr
Elastin-like polypeptides (ELPs) are promising biomaterials for medical applications due to their non-immunogenicity, scalable synthesis, and tunable self-assembly.
Stanford scientists have developed a plant-derived zinc protoporphyrin (ZnPP) produced from legume hemoglobin, a breakthrough therapy candidate for treating neonatal jaundice.
Stanford researchers have built a sound powered, wireless medical implant. The implant contains a piezoelectric energy receiver, an integrated circuit chip, and a loop antenna.
Stanford researchers have developed a stretchable, energy harvesting electronic skin (e-skin) that senses and distinguishes between normal pressure, tension, and bending. This human skin-like capability allows object manipulation, grasp control, and texture determination.
Of the 1.4 million first time mothers giving vaginal birth in the United States, approximately 75% will experience tearing of their vagina or perineum.